SELLAS (SLS) Surged 40% After Hours on New AML Data
SELLAS Life Sciences Group Inc. (NASDAQ:SLS) is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies designed…
Browsing Tag